LUMBOSACRAL PLEXUS INJURY

LUMBOSACRAL PLEXUS INJURY was reported 25 times

LUMBOSACRAL PLEXUS INJURY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimalarial [EPC] 1 0.0001
1 Antiprotozoal [EPC] 1 0.0001
2 Fluoroquinolone Antibacterial [EPC] 6 0.0000
3 Aluminum Complex [EPC] 1 0.0000
4 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 1 0.0000
5 Provitamin D2 Compound [EPC] 1 0.0000
6 Sympathomimetic-like Agent [EPC] 1 0.0000
7 Rifamycin Antibacterial [EPC] 1 0.0000
8 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
9 P2Y12 Platelet Inhibitor [EPC] 2 0.0000
10 Tetracycline-class Drug [EPC] 1 0.0000
11 Nitrate Vasodilator [EPC] 1 0.0000
12 RANK Ligand Inhibitor [EPC] 2 0.0000
13 Aromatase Inhibitor [EPC] 1 0.0000
14 Sulfonylurea [EPC] 1 0.0000
15 Calcineurin Inhibitor Immunosuppressant [EPC] 1 0.0000
16 alpha-Adrenergic Blocker [EPC] 1 0.0000
17 Aldosterone Antagonist [EPC] 1 0.0000
18 Azole Antifungal [EPC] 1 0.0000
19 Vitamin B12 [EPC] 2 0.0000
20 Expectorant [EPC] 1 0.0000
21 Thiazide Diuretic [EPC] 1 0.0000
22 Benzodiazepine [EPC] 3 0.0000
23 Opioid Agonist [EPC] 1 0.0000
24 Platinum-based Drug [EPC] 1 0.0000
25 Platelet Aggregation Inhibitor [EPC] 2 0.0000
26 Osmotic Laxative [EPC] 1 0.0000
27 Vitamin D [EPC] 1 0.0000
28 beta-Adrenergic Blocker [EPC] 1 0.0000
29 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
30 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
31 Vitamin C [EPC] 1 0.0000
32 GLP-1 Receptor Agonist [EPC] 1 0.0000
33 Atypical Antipsychotic [EPC] 1 0.0000
34 Tumor Necrosis Factor Blocker [EPC] 2 0.0000
35 Proton Pump Inhibitor [EPC] 1 0.0000
36 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000